STOK · Stoke Therapeutics, Inc. · Executive Compensation

$26.61 +1.79 (+7.21%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.60B

64.53M

Volume · Oct 20 2M Avg daily vol (3M) 896.52K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ian F. Smith	Chief Executive Officer	$170,625	$1,197,125	$11,590,000	$14,035,067	—	$38,838	$27,031,655
Edward M. Kaye	Former Chief Executive Officer	$148,726	—	$1,199,520	$1,298,138	—	$587,658	$3,234,043
Jason Hoitt	Chief Patient Officer	$494,401	—	$333,200	$1,121,337	$306,000	$15,017	$2,269,955
Thomas E. Leggett	CFO	$496,375	—	$491,470	$534,881	$297,825	$9,824	$1,830,375
Thomas Leggett	Chief Financial Officer	$496,375	—	$491,470	$534,881	$297,825	$9,824	$1,830,375

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Edward M. Kaye	Chief Executive Officer	$650,923	—	$2,975,700	$1,614,740	$358,008	$12,749	$5,612,120
Thomas E. Leggett	Chief Financial Officer	$309,470	—	—	$4,020,915	$190,001	—	$4,520,386
Thomas Leggett	Chief Financial Officer	$309,470	—	—	$4,020,915	$190,001	—	$4,520,386
Barry S. Ticho	M.D., Ph.D., FACC Chief Medical Officer	$514,030	—	$1,133,600	$609,336	$205,612	$6,859	$2,469,437

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Edward M. Kaye	Chief Executive Officer	$625,887	—	$1,299,300	$1,285,008	$309,814	$13,201	$3,533,210
Barry S. Ticho	M.D., Ph.D., FACC Chief Medical Officer	$494,259	—	$489,272	$474,186	$177,934	$12,356	$1,648,007
Stephen J. Tulipano	Chief Financial Officer	$458,640	—	$489,272	$474,186	$165,110	$11,273	$1,598,481
Thomas E. Leggett	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Edward M. Kaye	M.D . Chief Executive Officer	$596,083	$32,293	—	$4,817,310	$290,636	$12,200	$5,748,522
Barry S. Ticho	M.D., Ph.D., FACC Chief Medical Officer	$470,723	$20,712	—	$1,697,431	$186,407	$10,984	$2,386,257
Stephen J. Tulipano	Chief Financial Officer	$436,800	$17,210	—	$1,697,431	$154,890	$10,192	$2,316,523

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Edward M. Kaye	Chief Executive Officer	$567,698	$15,612	—	$7,604,990	$343,458	$11,600	$8,543,358
Barry S. Ticho	M.D., Ph.D., FACC Chief Medical Officer	$448,308	$8,966	—	$2,484,499	$197,257	$10,461	$3,149,491
Stephen J. Tulipano	Chief Financial Officer	$416,000	$8,320	—	$2,484,499	$183,040	$9,707	$3,101,566

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Barry S. Ticho	M.D., Ph.D., FACC Chief Medical Officer	$428,800	$8,576	—	$1,215,000	$214,400	$10,720	$1,877,496

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robin A. Walker	Chief Legal Officer, Chief Compliance Officer and Corporate Secretary	$56,061	$30,000	—	$1,155,481	—	—	$1,241,542
Stephen J. Tulipano	Chief Financial Officer	$294,318	—	—	$743,455	$129,500	$9,123	$1,176,396

Executive changes

Person	Role	Change	Effective	Filed
Alexander (Bo) Cumbo	Class III director	Appointed	2026-09-23	2026-09-25
Edward M. Kaye, M.D.	Class III director	Resigned	2026-09-23	2026-09-25
G. Clare Kahn, Ph.D.	Class I director	Appointed	2026-04-03	2026-04-07
Arthur Tzianabos	Interim Executive Chair of the Board	Resigned	2025-10-06	2025-10-06
Ian F. Smith	Chief Executive Officer	Appointed	2025-10-06	2025-10-06
Arthur Tzianabos	Interim Executive Chair of the Board	Appointed	2025-03-19	2025-03-18
Ian F. Smith	Interim Chief Executive Officer	Appointed	2025-03-19	2025-03-18
Stephen J. Tulipano	Chief Financial Officer	Resigned	2024-05-07	2024-04-29
Thomas Leggett	Chief Financial Officer	Appointed	2024-05-07	2024-04-29
Ian F. Smith	Class II director	Appointed	2023-09-19	2023-09-20

Leadership

Ian F. Smith CEO, Board Member
Arthur Tzianabos Chairman
Thomas E. Leggett CFO
Thomas Leggett CFO
Huw M. Nash COO
Jonathan Allan General Counsel
Alexander (Bo) Cumbo Board Member
G. Clare Kahn, Ph.D. Board Member
Garry Menzel, Ph.D. Board Member

Key facts CIK 1623526 CUSIP 86150R107 13F (30d) 10 filings 10 filers Visit website Investor relations